跳至主要内容
临床试验/NL-OMON36305
NL-OMON36305撤回2 期

ebulising Amoxicillin-Clavulanic Acid in Patients with COPD (NACAP) - NACAP

Medisch Spectrum Twente0 个研究点目标入组 30 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
撤回
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • A clinical diagnosis of COPD, as defined by GOLD criteria,
  • Admitted with signs and symptoms of an exacerbation of COPD, defined as an acute negative change from the baseline, reported by the patient, in dyspnoea and/or sputum volume and/or colour of sputum (yellowish or greenish sputum) and/or cough
  • Age 40 years or over
  • Current or former smoker.

排除标准

  • Impaired renal function (GFR < 30)
  • Current pneumonia, defined as an acute respiratory tract illness associated with radiographic shadowing on a chest radiograph which was neither pre-existing nor of any other cause.
  • Allergy for penicillin, amoxicillin or clavulanic acid
  • Respiratory insuffiency and hypercapnia measured by arterial blood gas analyses

研究者

相似试验